Kokubun H, Kijima T, Tokura Y, Uematsu T, et al. DeltaBSIJ: a quantitative marker for early detection of medication-related osteonecrosis of the jaw in patients with prostate cancer receiving bone-modifying agents. Ann Nucl Med 2025;39:1192-1200.
PMID: 40608250